Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococcus aureus (methicillin-susceptible) |
- |
1 |
? - ? |
Tobramycin (Tobrex, Nebcin) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
- |
1 |
? - ? |
Vancomycin (Vancocyn, Lyphocin) |
240 |
Staphylococcus aureus (methicillin-susceptible) |
- |
1 |
? - ? |
Vancomycin (Vancocyn, Lyphocin) |
1358 |
Staphylococcus aureus (methicillin-susceptible) |
- |
1 |
? - ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
Staphylococcus aureus (methicillin-susceptible) |
- |
2 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1358 |
Staphylococcus aureus (methicillin-susceptible) |
- |
2 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
602 |
Staphylococcus aureus (methicillin-susceptible) |
- |
2 |
? - ? |
Trimethoprim (Proloprim, Trimpex) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
- |
2 |
? - ? |
Vancomycin (Vancocyn, Lyphocin) |
303 |
Staphylococcus aureus (methicillin-susceptible) |
- |
2.5 |
? - ? |
Teicoplanin (Targocid) |
1112 |
Staphylococcus aureus (methicillin-susceptible) |
- |
3 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
Staphylococcus aureus (methicillin-susceptible) |
- |
4 |
? - ? |
Gatifloxacin (Tequin) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
- |
4 |
? - ? |
Moxifloxacin (BAY 12-8039, Avelox) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
- |
8 |
? - ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
602 |
Staphylococcus aureus (methicillin-susceptible) |
>- |
>8 |
? - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
>- |
>8 |
? - ? |
Polymyxin B (Aerospin) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
>- |
>16 |
? - ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
- |
16 |
? - ? |
Levofloxacin (Levaquin, Quixin) |
452 |
Staphylococcus aureus (methicillin-susceptible) |
- |
128 |
128 - 128 |
Aztreonam (Azactam) |
311 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
<=0.008 - 1 |
Ceftaroline |
1583 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.031 - ? |
Retapamulin |
609 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.031 - ? |
Retapamulin |
609 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.045 - ? |
DC-159a |
268 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.045 - ? |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.0625 - ? |
Ampicillin (Omnipen) |
1594 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.185 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.25 - 0.5 |
Cefotiam |
257 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.25 - 1 |
RWJ-416457 |
280 |
Staphylococcus aureus (methicillin-susceptible) |
- |
- |
0.25 - ? |
Cefotiam + FNQ3 |
257 |